|
CCDC132 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64790403545112E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.16173778666962E-14 |
| Normal-vs-Stage2 |
6.46979999999742E-05 |
| Normal-vs-Stage3 |
1.56920032523544E-10 |
| Normal-vs-Stage4 |
2.16215934045749E-12 |
| Stage1-vs-Stage2 |
2.457200E-01 |
| Stage1-vs-Stage3 |
4.757600E-01 |
| Stage1-vs-Stage4 |
3.472300E-02 |
| Stage2-vs-Stage3 |
1.289850E-01 |
| Stage2-vs-Stage4 |
1.523810E-02 |
| Stage3-vs-Stage4 |
1.805990E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.99680288865056E-15 |
| Normal-vs-AfricanAmerican |
2.66849999996932E-06 |
| Normal-vs-Asian |
1.41729999958429E-07 |
| Caucasian-vs-AfricanAmerican |
7.669400E-01 |
| Caucasian-vs-Asian |
3.574600E-01 |
| AfricanAmerican-vs-Asian |
7.303800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.59268170768701E-13 |
| Normal-vs-Female |
2.32514008047247E-12 |
| Male-vs-Female |
2.540400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.32054392263126E-12 |
| Normal-vs-Age(41-60Yrs) |
1.64019908766022E-11 |
| Normal-vs-Age(61-80Yrs) |
2.91339952163128E-10 |
| Normal-vs-Age(81-100Yrs) |
6.371200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.378000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.227800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.427800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.385200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.072200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.797400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.103050E-01 |
| Classical-VS-Follicular |
5.580400E-01 |
| Classical-VS-Other |
4.950600E-01 |
| Classical-VS-Normal |
1.86528570367273E-12 |
| Tall-VS-Follicular |
6.320500E-02 |
| Tall-VS-Other |
8.847400E-01 |
| Tall-VS-Normal |
3.3703000390517E-09 |
| Follicular-VS-Other |
4.806800E-01 |
| Follicular-VS-Normal |
1.02509999999612E-06 |
| Other-VS-Normal |
1.002130E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.20650045509763E-10 |
| Normal-vs-N1 |
6.77510270108428E-11 |
| N0-vs-N1 |
1.084430E-01 |
|
|
